To whom it may concern

Valenta Pharm Company by this letter informs about the sale of Novosibkhimpharm enterprise. Moreover, Valenta Pharm reserves the right on healthcare products of these brands: Multiplast®, Tigroviy and Krokha.

Thus, Valenta Pharm retains its strategic focus on the development, production and promotion of prescription and over-the-counter medicines in the pharmaceutical market in such therapeutic areas as immunology, virology and antibacterial therapy, psychoneurology, gastroenterology, dermatology, etc.